Olema Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
13.25
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.65
|
0.00
|
0.65
|
100.00%
|
|
2022-09-30
|
-0.77
|
-0.57
|
0.20
|
25.97%
|
|
2022-06-30
|
-0.64
|
-0.82
|
-0.18
|
-28.13%
|
|
2022-03-31
|
-0.57
|
-0.58
|
-0.01
|
-1.75%
|
|
2021-12-31
|
-0.49
|
-0.54
|
-0.05
|
-10.20%
|
|
2021-09-30
|
-0.46
|
-0.45
|
0.01
|
2.17%
|
|
2021-06-30
|
-0.38
|
-0.42
|
-0.04
|
-10.53%
|
|
2021-03-31
|
-0.28
|
-0.39
|
-0.11
|
-39.29%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.97
|
|
2021-12-31
|
-1.80
|
|
2020-12-31
|
-0.53
|